Channels :: FRELIP Discovery

Author: Khumalo, Fezokuhle Ncedile

Quick Look
Development and Characterization of a Modified Vaccinia Ankara Vaccine Candidate Expressing the SARS-CoV-2 Spike Glycoprotein

Similar Items: Development and Characterization of a Modified Vaccinia Ankara Vaccine Candidate Expressing the SARS-CoV-2 Spike Glycoprotein

Quick Look
In vitro characterization of the antiviral activity of Secomet V against vaccinia virus infections
Quick Look
Generation and characterization of HIV-1 subtype C candidate vaccines that will induce high titre antibody responses to HIV-1 envelope glycoprotein
Quick Look
The implementation of a rapid sample preparation method for the detection of SARS-CoV-2 in a diagnostic laboratory in South Africa
Quick Look
Recombinant BCG expressing HIV-1 C GAG : selection of the vaccine gene and construction and evaluation as a vaccine candidate
Quick Look
Evaluation of the in vivo role of vaccinia virus complement control protein (VCP) following renal ischemia
Quick Look
An investigation of the in vivo role of vaccinia virus complement control protein in head injury and Alzheimer's disease
Quick Look
An investigation of the impact of parasitic worm infection on the immunogenicity of candidate HIV vaccines
Quick Look
An investigation into the specific function of the vaccinia virus 13.8 kDa protein encoded by the N1
Quick Look
Pre-clinical assessment of novel candidate HIV-1 vaccines using the Chacma baboon
Quick Look
An investigation into the specific function of the vaccinia virus :13.8 kDa protein encoded by the N1L gene
Quick Look
Investigation of the use of recombinant BCG, expressing the major capsid protein (LI) of human papillomavirus type 16, as a candidate vaccine for cervical cancer
Quick Look
The development of novel HIV-1 vaccines using modified recombinant BCG
Quick Look
Recombinant BCG expressing rotavirus VP6 : construction and evaluation as an anti-rotavirus vaccine
Quick Look
Exploring the interactions of hyperglycaemia, SARS-CoV-2 spike protein & iron in HepG2 cells
Quick Look
New Variant of SARS-CoV-2 Dynamics with Imperfect Vaccine
Quick Look
An investigation into the Use of Lumpy Skin Disease Virus as a Vaccine Vector for a Potential HIV-1 vaccine
Quick Look
Anti-vector immune responses to an MVA vaccine
Quick Look
In-silico design of peptide inhibitors targeting the SARS-CoV-2 spike protein using mutagenesis-based remodelling
Quick Look
Comparison of the two lumpy skin disease virus vaccines, Neethling and Herbivac, and construction of a recombinant Herbivac-Rift Valley fever virus vaccine
Quick Look
Characterising the magnitude and breadth of T cell responses to SARS-CoV-2 vaccination
Quick Look
Investigation of local South African avipoxviruses as potential vaccine vectors
Quick Look
A study of the host-restricted lumpy skin disease virus as a vaccine vector using rabies babies virus as a model
Quick Look
Recombinant Salmonella enterica serovar Typhimurium vaccine vector expressing green fluorescent protein as a model antigen or human immunodeficiency virus type 1 subtype C Gag
Quick Look
Seroprevalence of anti-SARS-CoV-2 specific antibodies in vaccinated and vaccine naïve adult Nigerians